Nifty

:

22512.65

Sensex

:

72696.39

-601.85 (-2.60%)
-1836.57 (-2.46%)

Login

Nifty
Sensex

:
:

22512.65
72696.39

-601.85 (-2.60%)
-1836.57 (-2.46%)

Kobo Biotech Ltd.

Pharmaceuticals & Drugs

Rating :

N/A

BSE: 531541 | NSE: Not Listed

Watchlist

NSE BSE

2.27

23-Mar-2026

Open
High
Low
Previous Close

2.25
2.47
2.25
2.36

Volume
Traded Value (lacs)
52 Week High
52 Week Low

6597
15070
2.47
0

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

5.41
N/A
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

144.92
N/A
N/A

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-
-
-

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
-
-

PAT CAGR (%)

10 Years
5 Years
3 Years

-
-
-

P:E (Median)

8 Years
5 Years
3 Years

-
-
-

P:BV (Average)

8 Years
5 Years
3 Years

-
-
-

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-273.23
-271.49
-268.07

Quarterly Results

N/A

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 32.54 29.06 Net Sales Growth 0.00% 0 0 0 0 0 0 -100% 11.98% Cost Of Goods Sold 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 19.49 28.49 Gross Profit 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 13.05 0.56 GP Margin 0.00% 0 0 0 0 0 0 0 40.10% 1.93% Total Expenditure 0.99 1.50 143.87 2.79 2.61 2.99 3.08 4.04 28.66 38.98 Power & Fuel Cost - 0.12 0.10 0.28 0.42 0.31 0.24 0.28 2.03 0.81 % Of Sales - 0 0 0 0 0 0 0 6.24% 2.79% Employee Cost - 0.23 0.72 1.39 1.80 2.08 2.42 3.11 4.27 6.17 % Of Sales - 0 0 0 0 0 0 0 13.12% 21.23% Manufacturing Exp. - 0.00 0.00 0.00 0.00 0.00 0.00 0.06 1.38 0.43 % Of Sales - 0 0 0 0 0 0 0 4.24% 1.48% General & Admin Exp. - 0.14 0.11 0.15 0.14 0.21 0.11 0.16 1.48 3.06 % Of Sales - 0 0 0 0 0 0 0 4.55% 10.53% Selling & Distn. Exp. - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.02 % Of Sales - 0 0 0 0 0 0 0 0.03% 0.07% Miscellaneous Exp. - 1.01 142.94 0.96 0.25 0.39 0.31 0.42 0.00 0.00 % Of Sales - 0 0 0 0 0 0 0 0% 0% EBITDA -0.99 -1.50 -143.87 -2.79 -2.61 -2.99 -3.08 -4.04 3.88 -9.92 EBITDA Margin 0.00% 0 0 0 0 0 0 0 11.92% -34.14% Other Income 0.02 0.02 133.38 0.04 1.95 1.31 0.10 6.00 1.35 0.53 Interest 0.00 0.00 0.13 10.84 14.47 14.44 14.50 14.41 14.37 15.62 Depreciation 4.07 4.07 4.61 5.64 5.88 6.15 6.44 6.78 7.31 7.78 PBT -5.04 -5.55 -15.23 -19.23 -21.01 -22.27 -23.92 -19.24 -16.46 -32.79 Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Rate 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% PAT -5.04 -5.55 -15.23 -19.23 -21.01 -24.46 -23.92 -19.24 -16.46 -30.26 PAT before Minority Interest -5.04 -5.55 -15.23 -19.23 -21.01 -24.46 -23.92 -19.24 -16.46 -30.26 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 0.00% 0 0 0 0 0 0 0 -50.58% -104.13% PAT Growth 0.00% - - - - - - - - EPS -2.12 -2.33 -6.40 -8.08 -8.83 -10.28 -10.05 -8.08 -6.92 -12.71

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds -127.98 -122.43 -107.20 -87.97 -66.96 -42.51 -18.58 6.43 13.67 Share Capital 23.82 23.82 23.82 23.82 23.82 23.82 23.82 23.73 22.50 Total Reserves -151.81 -146.25 -131.03 -111.80 -90.79 -66.33 -42.41 -23.33 -8.83 Non-Current Liabilities 37.43 38.30 38.63 40.03 40.03 46.53 63.51 73.99 74.10 Secured Loans 0.95 1.82 1.82 3.22 3.22 9.72 26.69 31.82 30.00 Unsecured Loans 31.71 31.71 31.71 31.71 31.71 31.71 31.71 7.47 9.40 Long Term Provisions 1.78 1.78 2.11 2.11 2.11 2.11 2.11 0.00 0.00 Current Liabilities 165.88 163.31 299.16 284.27 266.38 241.91 207.30 180.06 164.07 Trade Payables 54.74 52.17 60.45 57.08 54.46 51.51 50.10 58.34 51.48 Other Current Liabilities 51.39 51.38 63.98 63.27 62.39 55.28 36.43 23.98 22.14 Short Term Borrowings 59.76 59.76 174.73 163.93 149.53 135.13 120.76 95.63 88.07 Short Term Provisions 0.00 0.00 0.00 0.00 0.00 0.00 0.00 2.11 2.38 Total Liabilities 75.33 79.18 230.59 236.33 239.45 245.93 252.23 260.48 251.84 Net Block 37.59 41.66 56.91 62.54 68.42 74.56 81.01 87.79 95.10 Gross Block 103.68 103.68 192.42 192.42 192.42 192.41 192.41 192.41 192.41 Accumulated Depreciation 66.09 62.02 135.51 129.88 124.00 117.85 111.41 104.62 97.31 Non Current Assets 37.59 41.66 71.36 76.99 82.87 89.01 95.45 102.24 109.55 Capital Work in Progress 0.00 0.00 2.25 2.25 2.25 2.25 2.25 2.25 2.25 Non Current Investment 0.00 0.00 12.19 12.19 12.19 12.19 12.19 12.19 12.19 Long Term Loans & Adv. 0.00 0.00 0.01 0.01 0.01 0.01 0.01 0.01 0.01 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 37.74 37.53 159.23 159.34 156.58 156.93 156.77 158.23 142.29 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 18.04 18.04 53.28 53.28 53.28 55.46 55.46 55.46 69.97 Sundry Debtors 11.95 11.80 92.47 93.29 90.61 88.83 88.74 89.73 56.16 Cash & Bank 0.13 0.13 1.56 0.13 0.13 0.13 0.13 0.59 0.24 Other Current Assets 7.62 0.01 0.03 0.12 12.56 12.51 12.43 12.44 15.91 Short Term Loans & Adv. 7.61 7.55 11.90 12.53 12.44 12.37 12.31 12.40 15.87 Net Current Assets -128.14 -125.79 -139.93 -124.93 -109.80 -84.98 -50.53 -21.82 -21.78 Total Assets 75.33 79.19 230.59 236.33 239.45 245.94 252.22 260.47 251.84

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 0.87 93.76 2.51 14.48 20.95 31.47 32.30 5.62 19.32 PBT -5.55 -15.23 -19.23 -21.01 -24.46 -23.92 -19.24 -16.46 -30.26 Adjustment 4.07 4.74 16.48 20.35 20.59 20.94 21.19 21.69 23.40 Changes in Working Capital 2.36 104.24 5.26 15.13 24.82 34.45 30.35 0.39 26.18 Cash after chg. in Working capital 0.87 93.76 2.51 14.48 20.95 31.47 32.30 5.62 19.32 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity 0.00 25.09 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Net Fixed Assets 0.00 90.99 0.00 0.00 -0.01 0.00 0.00 0.00 Net Investments 0.00 12.19 0.00 0.00 0.00 0.00 0.00 0.00 Others 0.00 -78.09 0.00 0.00 0.01 0.00 0.00 0.00 Cash from Financing Activity -0.87 -120.28 -1.08 -14.47 -20.95 -31.47 -32.76 -5.27 -20.50 Net Cash Inflow / Outflow 0.00 -1.43 1.43 0.00 0.00 0.00 -0.46 0.35 -1.18 Opening Cash & Equivalents 0.13 1.56 0.13 0.13 0.13 0.13 0.59 0.24 1.42 Closing Cash & Equivalent 0.13 0.13 1.56 0.13 0.13 0.13 0.13 0.59 0.24

Financial Ratios

Standalone /

Consolidated

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Book Value (Rs.) -53.72 -51.39 -45.00 -36.92 -28.11 -17.84 -7.80 0.17 6.08 19.81 ROA -7.19% -9.83% -8.24% -8.83% -10.08% -9.60% -7.50% -6.43% -11.40% -11.70% ROE 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -233.98% -103.90% -53.52% ROCE -36.84% -17.59% -5.31% -3.93% -5.74% -5.12% -2.78% -1.32% -8.67% -7.12% Fixed Asset Turnover 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.17 0.15 0.30 Receivable days 0.00 0.00 0.00 0.00 0.00 0.00 0.00 815.23 754.97 437.54 Inventory Days 0.00 0.00 0.00 0.00 0.00 0.00 0.00 700.86 907.25 428.22 Payable days 0.00 0.00 0.00 0.00 0.00 0.00 0.00 804.79 426.89 224.41 Cash Conversion Cycle 0.00 0.00 0.00 0.00 0.00 0.00 0.00 711.31 1235.34 641.35 Total Debt/Equity -1.09 -1.15 -2.43 -2.85 -3.53 -5.22 -11.17 384.13 10.42 3.07 Interest Cover 0.00 -111.95 -0.77 -0.45 -0.69 -0.65 -0.34 -0.15 -0.94 -0.77

Description Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 23.59 39.06 32.84 27.29 ROA -8.63% 3.61% 5.26% 3.94% ROE -49.39% 16.89% 23.17% 16.03% ROCE -4.10% 14.41% 19.89% 12.10% Fixed Asset Turnover 0.55 2.32 1.74 1.01 Receivable days 692.18 155.15 130.31 135.12 Inventory Days 237.52 45.72 58.01 105.14 Payable days 364.22 105.87 111.17 80.09 Cash Conversion Cycle 565.47 95.00 77.15 160.17 Total Debt/Equity 3.38 2.07 1.60 2.14 Interest Cover -0.43 1.81 1.86 1.73

Top Investors:

mehul pravin chandra shah

Annual Reports:

News Update:

No Latest News!

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback